KEQU - Kewaunee Scientific Corp Stock Price, Fair Value and News

35.55USD-0.85 (-2.34%)Delayed as of 24 Apr 2024, 11:33 am ET

Market Summary

USD35.55-0.85

Delayedas of 24 Apr 2024, 11:33 am

-2.34%

KEQU Alerts

2 major insider sales recently.

KEQU Stock Price

View Fullscreen

KEQU RSI Chart

KEQU Valuation

Market Cap

104.7M

Price/Earnings (Trailing)

11.99

Price/Sales (Trailing)

0.52

EV/EBITDA

4.41

Price/Free Cashflow

5.76

KEQU Price/Sales (Trailing)

KEQU Profitability

EBT Margin

7.01%

Return on Equity

19.81%

Return on Assets

6.91%

Free Cashflow Yield

17.37%

KEQU Fundamentals

KEQU Revenue

Revenue (TTM)

201.0M

Rev. Growth (Yr)

-23.09%

Rev. Growth (Qtr)

-7.25%

KEQU Earnings

Earnings (TTM)

8.7M

Earnings Growth (Yr)

248.69%

Earnings Growth (Qtr)

-7.72%

Breaking Down KEQU Revenue

52 Week Range

14.5636.78

(Low)(High)

Last 7 days

3.9%

Last 30 days

13.4%

Last 90 days

24.3%

Trailing 12 Months

132.9%

How does KEQU drawdown profile look like?

KEQU Financial Health

Current Ratio

2.28

KEQU Investor Care

Shares Dilution (1Y)

1.59%

Diluted EPS (TTM)

2.99

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	201.0M	0	0	0
2023	215.2M	219.5M	219.2M	215.1M
2022	157.9M	168.9M	179.5M	195.0M
2021	143.0M	147.5M	150.5M	150.6M
2020	148.0M	147.5M	144.6M	143.9M
2019	156.3M	146.6M	143.7M	146.2M
2018	148.1M	158.1M	166.3M	162.1M
2017	138.1M	138.6M	135.2M	140.3M
2016	124.8M	128.6M	134.8M	140.1M
2015	115.6M	118.8M	119.4M	120.2M
2014	115.9M	111.2M	109.7M	113.9M
2013	114.3M	117.1M	122.4M	117.4M
2012	100.8M	102.8M	103.2M	108.4M
2011	99.8M	100.0M	101.5M	101.8M
2010	0	99.1M	99.3M	99.5M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Kewaunee Scientific Corp

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 27, 2024	noble ryan s.	sold	-23,015	33.26	-692	vp-sales & marketing-americas
Mar 27, 2024	ranade mandar	sold	-13,240	33.1	-400	vp-information technology
Mar 26, 2024	phillips elizabeth d	sold	-106,502	32.5	-3,277	vp - human resources
Mar 26, 2024	noble ryan s.	sold	-1,914	33.00	-58.00	vp-sales & marketing-americas
Mar 15, 2024	batdorff douglas j.	sold	-109,725	31.35	-3,500	vp of manufacturing operations
Mar 14, 2024	ranade mandar	sold	-92,550	30.85	-3,000	vp-information technology
Jan 08, 2024	batdorff douglas j.	sold	-26,248	28.94	-907	vp of manufacturing operations
Dec 19, 2023	noble ryan s.	sold	-32,512	26.01	-1,250	vp-sales & marketing-americas
Dec 19, 2023	phillips elizabeth d	sold	-12,404	25.06	-495	vp - human resources
Dec 14, 2023	russell john	bought	26,030	23.75	1,096	-

Which funds bought or sold KEQU recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 05, 2024	CWM, LLC	unchanged	-	-	-	-%
Mar 11, 2024	VANGUARD GROUP INC	added	1.35	1,469,510	3,545,410	-%
Feb 14, 2024	BANK OF AMERICA CORP /DE/	new	-	29.00	29.00	-%
Feb 14, 2024	BRIDGEWAY CAPITAL MANAGEMENT, LLC	unchanged	-	345,648	883,728	0.02%
Feb 14, 2024	EARNEST PARTNERS LLC	sold off	-100	-12,075	-	-%
Feb 14, 2024	Royal Bank of Canada	added	382	2,000	2,000	-%
Feb 13, 2024	FMR LLC	unchanged	-	364	930	-%
Feb 13, 2024	ACADIAN ASSET MANAGEMENT LLC	unchanged	-	73,000	187,000	-%
Feb 13, 2024	MORGAN STANLEY	reduced	-4.31	269,906	710,471	-%

Are Funds Buying or Selling KEQU?

Are funds buying KEQU calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own KEQU

No. of Funds

KEQU Alerts

2 major insider sales recently.

Unveiling Kewaunee Scientific Corp's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	northern trust corp	10.4%	301,767	SC 13G/A
Feb 09, 2024	dimensional fund advisors lp	5.9%	171,601	SC 13G/A
Feb 09, 2024	minerva advisors llc	6.0%	-	SC 13G/A
Mar 10, 2023	zucker anita g	7.8%	221,361	SC 13D/A
Feb 14, 2023	minerva advisors llc	6.0%	-	SC 13G/A
Feb 13, 2023	northern trust corp	10.9%	309,069	SC 13G/A
Feb 10, 2023	dimensional fund advisors lp	6.6%	186,049	SC 13G/A
May 16, 2022	kamin peter	6.3%	176,674	SC 13D/A
Feb 14, 2022	minerva advisors llc	5.0%	-	SC 13G/A
Feb 08, 2022	northern trust corp	11.5%	321,895	SC 13G/A

Recent SEC filings of Kewaunee Scientific Corp

View All Filings

Date Filed	Form Type	Document
Apr 23, 2024	8-K	Current Report
Apr 11, 2024	4	Insider Trading
Mar 28, 2024	4	Insider Trading
Mar 26, 2024	144	Notice of Insider Sale Intent
Mar 26, 2024	4	Insider Trading
Mar 25, 2024	144	Notice of Insider Sale Intent
Mar 25, 2024	144	Notice of Insider Sale Intent
Mar 22, 2024	8-K	Current Report
Mar 18, 2024	4	Insider Trading
Mar 15, 2024	4	Insider Trading

Peers (Alternatives to Kewaunee Scientific Corp)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
HD	335.9B	152.7B	-13.16%	12.36%	22.18	2.2	-3.01%	-11.47%
LOW	133.6B	86.4B	-9.65%	11.22%	17.3	1.55	-11.01%	20.02%
DHI	47.0B	37.1B	-8.53%	36.40%	9.46	1.27	10.12%	-4.29%
NVR	24.9B	9.5B	-1.88%	31.07%	15.66	2.62	-9.58%	-7.76%
FND	11.7B	4.4B	-15.55%	11.17%	47.72	2.66	3.50%	-17.51%
MID-CAP
MHK	7.2B	11.1B	-9.41%	15.43%	-16.43	0.65	-5.13%	-1840.86%
IBP	6.8B	2.8B	-7.75%	93.21%	27.7	2.43	4.08%	9.09%
WHR	5.8B	19.5B	-4.84%	-25.04%	11.93	0.3	-1.36%	131.86%
CVCO	3.1B	1.9B	-4.64%	21.25%	18.3	1.69	-14.77%	-30.65%
CCS	2.7B	3.7B	-9.66%	25.98%	10.27	0.72	-18.06%	-50.64%
LEG	2.4B	4.7B	-3.04%	-42.30%	-17.8	0.52	-8.19%	-144.16%
SMALL-CAP
AMWD	1.5B	1.9B	-7.18%	80.97%	12.31	0.79	-10.13%	53.07%
BZH	879.5M	2.1B	-11.49%	61.31%	5.64	0.41	-6.89%	-25.76%
BSET	118.3M	369.0M	-9.40%	-7.90%	-20.37	0.32	-22.39%	-109.49%
CRWS	52.6M	86.7M	-7.89%	-9.19%	11.16	0.61	9.53%	-34.99%

Kewaunee Scientific Corp News

Latest updates

Kewaunee Scientific Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-7.3%	46,778,000	50,436,000	49,839,000	53,986,000	60,821,000	54,564,000	50,123,000	49,715,000	40,633,000	39,031,000	39,493,000	38,707,000	33,339,000	39,000,000	36,423,000	34,257,000	34,225,000	39,722,000	39,336,000	34,748,000	32,372,000
Gross Profit	-10.7%	12,029,000	13,468,000	11,914,000	10,361,000	10,330,000	8,701,000	6,196,000	9,327,000	5,622,000	3,597,000	5,674,000	6,063,000	5,654,000	6,395,000	5,881,000	4,887,000	5,278,000	6,316,000	6,946,000	4,842,000	5,230,000
Operating Expenses	-1.6%	8,223,000	8,359,000	8,106,000	7,660,000	8,026,000	7,946,000	6,592,000	7,086,000	6,490,000	6,487,000	6,765,000	6,716,000	6,030,000	6,406,000	6,157,000	5,897,000	7,350,000	6,355,000	6,170,000	6,323,000	5,232,000
EBITDA Margin	16.5%	0.09	0.08	0.06	0.04	0.04	0.03	0.01	0.01	-0.02	-0.02	0.00	0.00	-	-	-	-	-	-	-	-	-
Interest Expenses	10.5%	411,000	372,000	430,000	544,000	436,000	370,000	384,000	236,000	158,000	132,000	106,000	79,000	105,000	128,000	77,000	41,000	150,000	135,000	167,000	109,000	76,000
Income Taxes	-51.3%	982,000	2,015,000	897,000	1,228,000	962,000	570,000	379,000	2,673,000	399,000	195,000	251,000	1,979,000	-813,000	-197,000	21,000	-64,000	-350,000	2,003,000	169,000	-357,000	20,000
Earnings Before Taxes	-27.5%	3,515,000	4,845,000	3,412,000	2,322,000	2,060,000	456,000	-340,000	2,345,000	-887,000	-2,887,000	-1,056,000	-950,000	-718,000	-362,000	-587,000	-1,122,000	-2,251,000	-158,000	665,000	-1,554,000	35,000
EBT Margin	19.3%	0.07	0.06	0.04	0.02	0.02	0.01	-0.01	-0.01	-0.04	-0.04	-0.02	-0.02	-	-	-	-	-	-	-	-	-
Net Income	-7.7%	2,521,000	2,732,000	2,474,000	1,005,000	723,000	-243,000	-747,000	-362,000	-1,319,000	-3,100,000	-1,345,000	-2,975,000	81,000	-180,000	-598,000	-1,062,000	-1,918,000	-2,178,000	471,000	-1,270,000	-22,000
Net Income Margin	34.7%	0.04	0.03	0.02	0.00	0.00	-0.01	-0.03	-0.04	-0.06	-0.05	-0.03	-0.02	-	-	-	-	-	-	-	-	-
Free Cashflow	1171.8%	9,500,000	747,000	8,172,000	-243,000	-2,961,000	-4,271,000	3,685,000	-6,798,000	4,984,000	-4,295,000	-1,776,000	-2,195,000	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	3.8%	126	122	125	119	122	119	126	119	96.00	94.00	90.00	89.00	90.00	91.00	87.00	84.00	84.00	90.00	99.00	87.00	80.00
Current Assets	5.8%	96.00	91.00	94.00	88.00	92.00	91.00	98.00	92.00	69.00	67.00	62.00	60.00	60.00	62.00	58.00	54.00	53.00	61.00	69.00	65.00	60.00
Cash Equivalents	55.3%	21.00	14.00	13.00	8.00	18.00	16.00	22.00	7.00	6.00	6.00	5.00	6.00	6.00	6.00	5.00	5.00	6.00	10.00	13.00	11.00	11.00
Inventory	0.8%	22.00	22.00	22.00	22.00	21.00	25.00	25.00	24.00	20.00	18.00	18.00	17.00	16.00	16.00	16.00	15.00	15.00	15.00	16.00	17.00	17.00
Net PPE	-1.9%	17.00	18.00	17.00	16.00	15.00	15.00	15.00	15.00	15.00	16.00	16.00	16.00	16.00	16.00	17.00	16.00	16.00	16.00	17.00	16.00	15.00
Liabilities	3.4%	81.00	78.00	84.00	80.00	85.00	84.00	90.00	83.00	60.00	57.00	50.00	48.00	51.00	53.00	49.00	45.00	41.00	45.00	51.00	40.00	30.00
Current Liabilities	8.8%	42.00	39.00	44.00	40.00	44.00	43.00	50.00	42.00	48.00	44.00	36.00	34.00	32.00	34.00	31.00	27.00	25.00	30.00	38.00	33.00	24.00
Short Term Borrowings	-	-	-	-	4.00	-	-	-	2.00	-	-	-	7.00	-	-	-	5.00	-	-	-	-	-
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	1.00
LT Debt, Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.00	1.00	-
Shareholder's Equity	4.7%	44.00	42.00	39.00	37.00	35.00	34.00	35.00	36.00	36.00	37.00	40.00	41.00	38.00	38.00	38.00	38.00	43.00	44.00	47.00	47.00	49.00
Retained Earnings	7.4%	36.00	34.00	31.00	29.00	28.00	27.00	27.00	28.00	28.00	30.00	33.00	34.00	37.00	37.00	37.00	38.00	39.00	41.00	44.00	44.00	45.00
Additional Paid-In Capital	5.0%	5.00	5.00	5.00	5.00	5.00	5.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	4.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00
Accumulated Depreciation	1.8%	47.00	46.00	46.00	45.00	47.00	47.00	46.00	45.00	45.00	44.00	44.00	43.00	43.00	43.00	42.00	42.00	42.00	41.00	41.00	40.00	42.00
Shares Outstanding	-0.9%	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	3.00	-	-	-	-	-	-	-	-	-
Minority Interest	-3.6%	1.00	1.00	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.00	1.00	1.00	1.00
Float	-	-	-	-	-	-	38.00	-	-	-	32.00	-	-	-	21.00	-	-	-	41.00	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	1171.8%	9,500	747	8,172	-243	-2,961	-4,271	3,685	-6,798	4,984	-4,295	-1,776	-2,195	3,623	2,752	-3,268	-450	115	4,903	-407	-2,044	2,233
Share Based Compensation	0%	241	241	183	187	331	196	172	227	136	150	216	249	129	144	112	10.00	126	41.00	74.00	-196	118
Cashflow From Investing	62.5%	-475	-1,265	-1,654	-2,586	-643	-529	-390	-686	-292	-446	-484	-453	-652	-370	-922	-1,094	-656	468	-1,183	-1,923	-979
Cashflow From Financing	-564.6%	-3,633	782	1,306	-2,158	5,564	-145	11,670	8,912	-4,738	4,836	2,021	2,361	-3,171	-993	3,785	698	-2,982	-8,108	2,934	3,568	-409
Dividend Payments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.00	-	523	522	523	521

KEQU Income Statement

2024-01-31

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jan. 31, 2024	Jan. 31, 2023	Jan. 31, 2024	Jan. 31, 2023
Income Statement [Abstract]
Net sales	$ 46,778	$ 60,821	$ 147,053	$ 165,508
Cost of products sold	34,749	50,491	109,642	140,281
Gross profit	12,029	10,330	37,411	25,227
Operating expenses	8,223	8,026	24,688	22,564
Operating profit	3,806	2,304	12,723	2,663
Pension expense	(41)	(18)	(122)	(53)
Other income, net	161	210	384	756
Interest expense	(411)	(436)	(1,213)	(1,190)
Profit before income taxes	3,515	2,060	11,772	2,176
Income tax expense	982	962	3,894	1,911
Net earnings	2,533	1,098	7,878	265
Less: Net earnings attributable to the non-controlling interest	12	375	151	532
Net earnings (loss) attributable to Kewaunee Scientific Corporation	$ 2,521	$ 723	$ 7,727	$ (267)
Net earnings (loss) per share attributable to Kewaunee Scientific Corporation stockholders
Basic (in dollars per share)	$ 0.87	$ 0.26	$ 2.68	$ (0.09)
Diluted (in dollars per share)	$ 0.85	$ 0.25	$ 2.64	$ (0.09)
Weighted average number of common shares outstanding
Basic (in shares)	2,893	2,830	2,885	2,822
Diluted (in shares)	2,965	2,911	2,927	2,822

KEQU Balance Sheet

2024-01-31

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jan. 31, 2024	Apr. 30, 2023
Current Assets:
Cash and cash equivalents	$ 21,312	$ 8,078
Restricted cash	5,800	5,737
Receivables, less allowance; $589; $476, on each respective date	41,109	46,081
Inventories	21,845	21,889
Prepaid expenses and other current assets	6,090	6,135
Total Current Assets	96,156	87,920
Property, plant and equipment, at cost	64,208	61,368
Accumulated depreciation	(46,716)	(44,966)
Net Property, Plant and Equipment	17,492	16,402
Right of use assets	7,827	9,170
Other assets	4,830	5,406
Total Assets	126,305	118,898
Current Liabilities:
Short-term borrowings	3,184	3,587
Current portion of financing liability	695	642
Current portion of financing lease liabilities	110	85
Current portion of operating lease liabilities	2,056	1,967
Accounts payable	19,083	23,599
Employee compensation and amounts withheld	5,766	4,304
Deferred revenue	10,248	4,097
Other accrued expenses	1,000	1,772
Total Current Liabilities	42,142	40,053
Long-term portion of financing liability	27,603	28,132
Long-term portion of financing lease liabilities	247	148
Long-term portion of operating lease liabilities	5,741	7,136
Accrued pension and deferred compensation costs	3,655	3,546
Deferred income taxes	1,134	943
Other non-current liabilities	441	455
Total Liabilities	80,963	80,413
Commitments and Contingencies
Stockholders' Equity:
Common stock, $2.50 par value, Authorized – 5,000 shares; Issued – 2,908 shares; 2,833 shares; – Outstanding – 2,875 shares; 2,830 shares, on each respective date	7,270	7,084
Additional paid-in-capital	5,046	5,059
Retained earnings	36,488	28,761
Accumulated other comprehensive loss	(3,877)	(3,442)
Common stock in treasury, at cost, 33 shares; 3 shares, on each respective date	(844)	(53)
Total Kewaunee Scientific Corporation Stockholders' Equity	44,083	37,409
Non-controlling interest	1,259	1,076
Total Stockholders' Equity	45,342	38,485
Total Liabilities and Stockholders' Equity	$ 126,305	$ 118,898

About Kewaunee Scientific Corp

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.

CEO	Mr. Thomas D. Hull III
WEBSITE	kewaunee.com
INDUSTRY	Home Improvement Retail
EMPLOYEES	982

Kewaunee Scientific Corp Frequently Asked Questions

What is the ticker symbol for Kewaunee Scientific Corp? What does KEQU stand for in stocks?

KEQU is the stock ticker symbol of Kewaunee Scientific Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Kewaunee Scientific Corp (KEQU)?

As of Tue Apr 23 2024, market cap of Kewaunee Scientific Corp is 104.65 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of KEQU stock?

You can check KEQU's fair value in chart for subscribers.

What is the fair value of KEQU stock?

You can check KEQU's fair value in chart for subscribers. The fair value of Kewaunee Scientific Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Kewaunee Scientific Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for KEQU so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Kewaunee Scientific Corp a good stock to buy?

The fair value guage provides a quick view whether KEQU is over valued or under valued. Whether Kewaunee Scientific Corp is cheap or expensive depends on the assumptions which impact Kewaunee Scientific Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for KEQU.

What is Kewaunee Scientific Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 23 2024, KEQU's PE ratio (Price to Earnings) is 11.99 and Price to Sales (PS) ratio is 0.52. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. KEQU PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Kewaunee Scientific Corp's stock?

In the past 10 years, Kewaunee Scientific Corp has provided 0.098 (multiply by 100 for percentage) rate of return.